Estrogen and Progesterone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Progesterone and estrogen are the two most important hormones in the female body. These are steroid hormones that are responsible for various female characteristics in the body.

The global market for Estrogen and Progesterone was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Estrogen and Progesterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Estrogen and Progesterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Estrogen and Progesterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Estrogen and Progesterone include Gedeon Richter, Bayer, N.V.Organon, Pfizer Healthcare, Jenapharm, Besins Healthcare, MERCK SERONO, Abbott and Teva Pharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Estrogen and Progesterone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Estrogen and Progesterone by region & country, by Type, and by Application.

The Estrogen and Progesterone market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Estrogen and Progesterone.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Estrogen and Progesterone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Estrogen and Progesterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Estrogen and Progesterone in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Estrogen and Progesterone Product Introduction
    1.2 Global Estrogen and Progesterone Market Size Forecast
        1.2.1 Global Estrogen and Progesterone Sales Value (2019-2030)
        1.2.2 Global Estrogen and Progesterone Sales Volume (2019-2030)
        1.2.3 Global Estrogen and Progesterone Sales Price (2019-2030)
    1.3 Estrogen and Progesterone Market Trends & Drivers
        1.3.1 Estrogen and Progesterone Industry Trends
        1.3.2 Estrogen and Progesterone Market Drivers & Opportunity
        1.3.3 Estrogen and Progesterone Market Challenges
        1.3.4 Estrogen and Progesterone Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Estrogen and Progesterone Players Revenue Ranking (2023)
    2.2 Global Estrogen and Progesterone Revenue by Company (2019-2024)
    2.3 Global Estrogen and Progesterone Players Sales Volume Ranking (2023)
    2.4 Global Estrogen and Progesterone Sales Volume by Company Players (2019-2024)
    2.5 Global Estrogen and Progesterone Average Price by Company (2019-2024)
    2.6 Key Manufacturers Estrogen and Progesterone Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Estrogen and Progesterone Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Estrogen and Progesterone
    2.9 Estrogen and Progesterone Market Competitive Analysis
        2.9.1 Estrogen and Progesterone Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Estrogen and Progesterone Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Estrogen and Progesterone as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Estrogen
        3.1.2 Progesterone
    3.2 Global Estrogen and Progesterone Sales Value by Type
        3.2.1 Global Estrogen and Progesterone Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Estrogen and Progesterone Sales Value, by Type (2019-2030)
        3.2.3 Global Estrogen and Progesterone Sales Value, by Type (%) (2019-2030)
    3.3 Global Estrogen and Progesterone Sales Volume by Type
        3.3.1 Global Estrogen and Progesterone Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Estrogen and Progesterone Sales Volume, by Type (2019-2030)
        3.3.3 Global Estrogen and Progesterone Sales Volume, by Type (%) (2019-2030)
    3.4 Global Estrogen and Progesterone Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Pharmacy
        4.1.2 Hospital
        4.1.3 Department of Endocrinology
    4.2 Global Estrogen and Progesterone Sales Value by Application
        4.2.1 Global Estrogen and Progesterone Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Estrogen and Progesterone Sales Value, by Application (2019-2030)
        4.2.3 Global Estrogen and Progesterone Sales Value, by Application (%) (2019-2030)
    4.3 Global Estrogen and Progesterone Sales Volume by Application
        4.3.1 Global Estrogen and Progesterone Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Estrogen and Progesterone Sales Volume, by Application (2019-2030)
        4.3.3 Global Estrogen and Progesterone Sales Volume, by Application (%) (2019-2030)
    4.4 Global Estrogen and Progesterone Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Estrogen and Progesterone Sales Value by Region
        5.1.1 Global Estrogen and Progesterone Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Estrogen and Progesterone Sales Value by Region (2019-2024)
        5.1.3 Global Estrogen and Progesterone Sales Value by Region (2025-2030)
        5.1.4 Global Estrogen and Progesterone Sales Value by Region (%), (2019-2030)
    5.2 Global Estrogen and Progesterone Sales Volume by Region
        5.2.1 Global Estrogen and Progesterone Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Estrogen and Progesterone Sales Volume by Region (2019-2024)
        5.2.3 Global Estrogen and Progesterone Sales Volume by Region (2025-2030)
        5.2.4 Global Estrogen and Progesterone Sales Volume by Region (%), (2019-2030)
    5.3 Global Estrogen and Progesterone Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Estrogen and Progesterone Sales Value, 2019-2030
        5.4.2 North America Estrogen and Progesterone Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Estrogen and Progesterone Sales Value, 2019-2030
        5.5.2 Europe Estrogen and Progesterone Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Estrogen and Progesterone Sales Value, 2019-2030
        5.6.2 Asia Pacific Estrogen and Progesterone Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Estrogen and Progesterone Sales Value, 2019-2030
        5.7.2 South America Estrogen and Progesterone Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Estrogen and Progesterone Sales Value, 2019-2030
        5.8.2 Middle East & Africa Estrogen and Progesterone Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Estrogen and Progesterone Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Estrogen and Progesterone Sales Value
        6.2.1 Key Countries/Regions Estrogen and Progesterone Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Estrogen and Progesterone Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Estrogen and Progesterone Sales Value, 2019-2030
        6.3.2 United States Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Estrogen and Progesterone Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Estrogen and Progesterone Sales Value, 2019-2030
        6.4.2 Europe Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Estrogen and Progesterone Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Estrogen and Progesterone Sales Value, 2019-2030
        6.5.2 China Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Estrogen and Progesterone Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Estrogen and Progesterone Sales Value, 2019-2030
        6.6.2 Japan Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Estrogen and Progesterone Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Estrogen and Progesterone Sales Value, 2019-2030
        6.7.2 South Korea Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Estrogen and Progesterone Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Estrogen and Progesterone Sales Value, 2019-2030
        6.8.2 Southeast Asia Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Estrogen and Progesterone Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Estrogen and Progesterone Sales Value, 2019-2030
        6.9.2 India Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Estrogen and Progesterone Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Gedeon Richter
        7.1.1 Gedeon Richter Company Information
        7.1.2 Gedeon Richter Introduction and Business Overview
        7.1.3 Gedeon Richter Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Gedeon Richter Estrogen and Progesterone Product Offerings
        7.1.5 Gedeon Richter Recent Development
    7.2 Bayer
        7.2.1 Bayer Company Information
        7.2.2 Bayer Introduction and Business Overview
        7.2.3 Bayer Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Bayer Estrogen and Progesterone Product Offerings
        7.2.5 Bayer Recent Development
    7.3 N.V.Organon
        7.3.1 N.V.Organon Company Information
        7.3.2 N.V.Organon Introduction and Business Overview
        7.3.3 N.V.Organon Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 N.V.Organon Estrogen and Progesterone Product Offerings
        7.3.5 N.V.Organon Recent Development
    7.4 Pfizer Healthcare
        7.4.1 Pfizer Healthcare Company Information
        7.4.2 Pfizer Healthcare Introduction and Business Overview
        7.4.3 Pfizer Healthcare Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Pfizer Healthcare Estrogen and Progesterone Product Offerings
        7.4.5 Pfizer Healthcare Recent Development
    7.5 Jenapharm
        7.5.1 Jenapharm Company Information
        7.5.2 Jenapharm Introduction and Business Overview
        7.5.3 Jenapharm Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Jenapharm Estrogen and Progesterone Product Offerings
        7.5.5 Jenapharm Recent Development
    7.6 Besins Healthcare
        7.6.1 Besins Healthcare Company Information
        7.6.2 Besins Healthcare Introduction and Business Overview
        7.6.3 Besins Healthcare Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Besins Healthcare Estrogen and Progesterone Product Offerings
        7.6.5 Besins Healthcare Recent Development
    7.7 MERCK SERONO
        7.7.1 MERCK SERONO Company Information
        7.7.2 MERCK SERONO Introduction and Business Overview
        7.7.3 MERCK SERONO Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 MERCK SERONO Estrogen and Progesterone Product Offerings
        7.7.5 MERCK SERONO Recent Development
    7.8 Abbott
        7.8.1 Abbott Company Information
        7.8.2 Abbott Introduction and Business Overview
        7.8.3 Abbott Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Abbott Estrogen and Progesterone Product Offerings
        7.8.5 Abbott Recent Development
    7.9 Teva Pharma
        7.9.1 Teva Pharma Company Information
        7.9.2 Teva Pharma Introduction and Business Overview
        7.9.3 Teva Pharma Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Teva Pharma Estrogen and Progesterone Product Offerings
        7.9.5 Teva Pharma Recent Development
    7.10 Aspen Pharmacare
        7.10.1 Aspen Pharmacare Company Information
        7.10.2 Aspen Pharmacare Introduction and Business Overview
        7.10.3 Aspen Pharmacare Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Aspen Pharmacare Estrogen and Progesterone Product Offerings
        7.10.5 Aspen Pharmacare Recent Development
    7.11 Dr.Kade Pharmazeutische Fabrik
        7.11.1 Dr.Kade Pharmazeutische Fabrik Company Information
        7.11.2 Dr.Kade Pharmazeutische Fabrik Introduction and Business Overview
        7.11.3 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Offerings
        7.11.5 Dr.Kade Pharmazeutische Fabrik Recent Development
    7.12 F.I.S.-FABBRICA
        7.12.1 F.I.S.-FABBRICA Company Information
        7.12.2 F.I.S.-FABBRICA Introduction and Business Overview
        7.12.3 F.I.S.-FABBRICA Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 F.I.S.-FABBRICA Estrogen and Progesterone Product Offerings
        7.12.5 F.I.S.-FABBRICA Recent Development
    7.13 Eli Lilly
        7.13.1 Eli Lilly Company Information
        7.13.2 Eli Lilly Introduction and Business Overview
        7.13.3 Eli Lilly Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Eli Lilly Estrogen and Progesterone Product Offerings
        7.13.5 Eli Lilly Recent Development
    7.14 Orion
        7.14.1 Orion Company Information
        7.14.2 Orion Introduction and Business Overview
        7.14.3 Orion Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Orion Estrogen and Progesterone Product Offerings
        7.14.5 Orion Recent Development
    7.15 AstraZeneca
        7.15.1 AstraZeneca Company Information
        7.15.2 AstraZeneca Introduction and Business Overview
        7.15.3 AstraZeneca Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 AstraZeneca Estrogen and Progesterone Product Offerings
        7.15.5 AstraZeneca Recent Development
    7.16 Novartis Pharma
        7.16.1 Novartis Pharma Company Information
        7.16.2 Novartis Pharma Introduction and Business Overview
        7.16.3 Novartis Pharma Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.16.4 Novartis Pharma Estrogen and Progesterone Product Offerings
        7.16.5 Novartis Pharma Recent Development
    7.17 Novo Nordisk
        7.17.1 Novo Nordisk Company Information
        7.17.2 Novo Nordisk Introduction and Business Overview
        7.17.3 Novo Nordisk Estrogen and Progesterone Sales, Revenue and Gross Margin (2019-2024)
        7.17.4 Novo Nordisk Estrogen and Progesterone Product Offerings
        7.17.5 Novo Nordisk Recent Development

 8 Industry Chain Analysis
    8.1 Estrogen and Progesterone Industrial Chain
    8.2 Estrogen and Progesterone Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Estrogen and Progesterone Sales Model
        8.5.2 Sales Channel
        8.5.3 Estrogen and Progesterone Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Estrogen and Progesterone Market Trends
    Table 2. Estrogen and Progesterone Market Drivers & Opportunity
    Table 3. Estrogen and Progesterone Market Challenges
    Table 4. Estrogen and Progesterone Market Restraints
    Table 5. Global Estrogen and Progesterone Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Estrogen and Progesterone Revenue Market Share by Company (2019-2024)
    Table 7. Global Estrogen and Progesterone Sales Volume by Company (2019-2024) & (K Pcs)
    Table 8. Global Estrogen and Progesterone Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Estrogen and Progesterone Price by Company (2019-2024) & (USD/Pcs)
    Table 10. Key Manufacturers Estrogen and Progesterone Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Estrogen and Progesterone Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Estrogen and Progesterone
    Table 13. Global Estrogen and Progesterone Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Estrogen and Progesterone as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Estrogen and Progesterone Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Estrogen and Progesterone Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Estrogen and Progesterone Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Estrogen and Progesterone Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Estrogen and Progesterone Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Estrogen and Progesterone Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)
    Table 22. Global Estrogen and Progesterone Sales Volume by Type (2019-2024) & (K Pcs)
    Table 23. Global Estrogen and Progesterone Sales Volume by Type (2025-2030) & (K Pcs)
    Table 24. Global Estrogen and Progesterone Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Estrogen and Progesterone Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Estrogen and Progesterone Price by Type (2019-2024) & (USD/Pcs)
    Table 27. Global Estrogen and Progesterone Price by Type (2025-2030) & (USD/Pcs)
    Table 28. Global Estrogen and Progesterone Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Estrogen and Progesterone Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Estrogen and Progesterone Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Estrogen and Progesterone Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Estrogen and Progesterone Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Estrogen and Progesterone Sales Volume by Application: 2019 VS 2023 VS 2030 (K Pcs)
    Table 34. Global Estrogen and Progesterone Sales Volume by Application (2019-2024) & (K Pcs)
    Table 35. Global Estrogen and Progesterone Sales Volume by Application (2025-2030) & (K Pcs)
    Table 36. Global Estrogen and Progesterone Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Estrogen and Progesterone Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Estrogen and Progesterone Price by Application (2019-2024) & (USD/Pcs)
    Table 39. Global Estrogen and Progesterone Price by Application (2025-2030) & (USD/Pcs)
    Table 40. Global Estrogen and Progesterone Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Estrogen and Progesterone Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Estrogen and Progesterone Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Estrogen and Progesterone Sales Value by Region (2019-2024) & (%)
    Table 44. Global Estrogen and Progesterone Sales Value by Region (2025-2030) & (%)
    Table 45. Global Estrogen and Progesterone Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030
    Table 46. Global Estrogen and Progesterone Sales Volume by Region (2019-2024) & (K Pcs)
    Table 47. Global Estrogen and Progesterone Sales Volume by Region (2025-2030) & (K Pcs)
    Table 48. Global Estrogen and Progesterone Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Estrogen and Progesterone Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Estrogen and Progesterone Average Price by Region (2019-2024) & (USD/Pcs)
    Table 51. Global Estrogen and Progesterone Average Price by Region (2025-2030) & (USD/Pcs)
    Table 52. Key Countries/Regions Estrogen and Progesterone Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Estrogen and Progesterone Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Estrogen and Progesterone Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Estrogen and Progesterone Sales Volume, (2019-2024) & (K Pcs)
    Table 56. Key Countries/Regions Estrogen and Progesterone Sales Volume, (2025-2030) & (K Pcs)
    Table 57. Gedeon Richter Company Information
    Table 58. Gedeon Richter Introduction and Business Overview
    Table 59. Gedeon Richter Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 60. Gedeon Richter Estrogen and Progesterone Product Offerings
    Table 61. Gedeon Richter Recent Development
    Table 62. Bayer Company Information
    Table 63. Bayer Introduction and Business Overview
    Table 64. Bayer Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 65. Bayer Estrogen and Progesterone Product Offerings
    Table 66. Bayer Recent Development
    Table 67. N.V.Organon Company Information
    Table 68. N.V.Organon Introduction and Business Overview
    Table 69. N.V.Organon Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 70. N.V.Organon Estrogen and Progesterone Product Offerings
    Table 71. N.V.Organon Recent Development
    Table 72. Pfizer Healthcare Company Information
    Table 73. Pfizer Healthcare Introduction and Business Overview
    Table 74. Pfizer Healthcare Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 75. Pfizer Healthcare Estrogen and Progesterone Product Offerings
    Table 76. Pfizer Healthcare Recent Development
    Table 77. Jenapharm Company Information
    Table 78. Jenapharm Introduction and Business Overview
    Table 79. Jenapharm Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 80. Jenapharm Estrogen and Progesterone Product Offerings
    Table 81. Jenapharm Recent Development
    Table 82. Besins Healthcare Company Information
    Table 83. Besins Healthcare Introduction and Business Overview
    Table 84. Besins Healthcare Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 85. Besins Healthcare Estrogen and Progesterone Product Offerings
    Table 86. Besins Healthcare Recent Development
    Table 87. MERCK SERONO Company Information
    Table 88. MERCK SERONO Introduction and Business Overview
    Table 89. MERCK SERONO Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 90. MERCK SERONO Estrogen and Progesterone Product Offerings
    Table 91. MERCK SERONO Recent Development
    Table 92. Abbott Company Information
    Table 93. Abbott Introduction and Business Overview
    Table 94. Abbott Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 95. Abbott Estrogen and Progesterone Product Offerings
    Table 96. Abbott Recent Development
    Table 97. Teva Pharma Company Information
    Table 98. Teva Pharma Introduction and Business Overview
    Table 99. Teva Pharma Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 100. Teva Pharma Estrogen and Progesterone Product Offerings
    Table 101. Teva Pharma Recent Development
    Table 102. Aspen Pharmacare Company Information
    Table 103. Aspen Pharmacare Introduction and Business Overview
    Table 104. Aspen Pharmacare Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 105. Aspen Pharmacare Estrogen and Progesterone Product Offerings
    Table 106. Aspen Pharmacare Recent Development
    Table 107. Dr.Kade Pharmazeutische Fabrik Company Information
    Table 108. Dr.Kade Pharmazeutische Fabrik Introduction and Business Overview
    Table 109. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 110. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Offerings
    Table 111. Dr.Kade Pharmazeutische Fabrik Recent Development
    Table 112. F.I.S.-FABBRICA Company Information
    Table 113. F.I.S.-FABBRICA Introduction and Business Overview
    Table 114. F.I.S.-FABBRICA Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 115. F.I.S.-FABBRICA Estrogen and Progesterone Product Offerings
    Table 116. F.I.S.-FABBRICA Recent Development
    Table 117. Eli Lilly Company Information
    Table 118. Eli Lilly Introduction and Business Overview
    Table 119. Eli Lilly Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 120. Eli Lilly Estrogen and Progesterone Product Offerings
    Table 121. Eli Lilly Recent Development
    Table 122. Orion Company Information
    Table 123. Orion Introduction and Business Overview
    Table 124. Orion Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 125. Orion Estrogen and Progesterone Product Offerings
    Table 126. Orion Recent Development
    Table 127. AstraZeneca Company Information
    Table 128. AstraZeneca Introduction and Business Overview
    Table 129. AstraZeneca Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 130. AstraZeneca Estrogen and Progesterone Product Offerings
    Table 131. AstraZeneca Recent Development
    Table 132. Novartis Pharma Company Information
    Table 133. Novartis Pharma Introduction and Business Overview
    Table 134. Novartis Pharma Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 135. Novartis Pharma Estrogen and Progesterone Product Offerings
    Table 136. Novartis Pharma Recent Development
    Table 137. Novo Nordisk Company Information
    Table 138. Novo Nordisk Introduction and Business Overview
    Table 139. Novo Nordisk Estrogen and Progesterone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 140. Novo Nordisk Estrogen and Progesterone Product Offerings
    Table 141. Novo Nordisk Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Estrogen and Progesterone Downstream Customers
    Table 145. Estrogen and Progesterone Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Estrogen and Progesterone Product Picture
    Figure 2. Global Estrogen and Progesterone Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Estrogen and Progesterone Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Estrogen and Progesterone Sales Volume (2019-2030) & (K Pcs)
    Figure 5. Global Estrogen and Progesterone Sales Price (2019-2030) & (USD/Pcs)
    Figure 6. Estrogen and Progesterone Report Years Considered
    Figure 7. Global Estrogen and Progesterone Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Estrogen and Progesterone Players Sales Volume Ranking (2023) & (K Pcs)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Estrogen and Progesterone Revenue in 2023
    Figure 10. Estrogen and Progesterone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Estrogen Picture
    Figure 12. Progesterone Picture
    Figure 13. Global Estrogen and Progesterone Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Estrogen and Progesterone Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Estrogen and Progesterone Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 16. Global Estrogen and Progesterone Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Estrogen and Progesterone Price by Type (2019-2030) & (USD/Pcs)
    Figure 18. Product Picture of Pharmacy
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Department of Endocrinology
    Figure 21. Global Estrogen and Progesterone Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Estrogen and Progesterone Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Estrogen and Progesterone Sales Volume by Application (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 24. Global Estrogen and Progesterone Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Estrogen and Progesterone Price by Application (2019-2030) & (USD/Pcs)
    Figure 26. North America Estrogen and Progesterone Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Estrogen and Progesterone Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Estrogen and Progesterone Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Estrogen and Progesterone Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Estrogen and Progesterone Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Estrogen and Progesterone Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Estrogen and Progesterone Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Estrogen and Progesterone Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Estrogen and Progesterone Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Estrogen and Progesterone Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Estrogen and Progesterone Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Estrogen and Progesterone Sales Volume (%), (2019-2030)
    Figure 38. United States Estrogen and Progesterone Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Estrogen and Progesterone Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Estrogen and Progesterone Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Estrogen and Progesterone Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Estrogen and Progesterone Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Estrogen and Progesterone Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Estrogen and Progesterone Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Estrogen and Progesterone Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Estrogen and Progesterone Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Estrogen and Progesterone Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Estrogen and Progesterone Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Estrogen and Progesterone Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Estrogen and Progesterone Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Estrogen and Progesterone Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Estrogen and Progesterone Sales Value by Application (%), 2023 VS 2030
    Figure 59. Estrogen and Progesterone Industrial Chain
    Figure 60. Estrogen and Progesterone Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

Progesterone and estrogen are the two most important hormones in the female body. These are steroid hormones that are responsible for various female characteristics in the body.

The global market for Estrogen and Progesterone was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Estrogen and Progesterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Estrogen and Progesterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Estrogen and Progesterone was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Estrogen and Progesterone include Gedeon Richter, Bayer, N.V.Organon, Pfizer Healthcare, Jenapharm, Besins Healthcare, MERCK SERONO, Abbott and Teva Pharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Estrogen and Progesterone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Estrogen and Progesterone by region & country, by Type, and by Application.

The Estrogen and Progesterone market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Estrogen and Progesterone.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Estrogen and Progesterone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Estrogen and Progesterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Estrogen and Progesterone in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.